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KNOWLEDGE-BASED MEDICATION ADMINISTRATION: PROGRAM EVALUATION 




University of New Hampshire, May 2015 
It has been reported by members of The Institute of Medicine that a patient is at risk for 
one medication administration error per day when hospitalized, thus prevention of medication 
administration errors is a priority patient safety goal.  One recommendation to reduce the 
prevalence of medication administration errors is the use of barcoded medication administration 
(BCMA) systems.  While there are many benefits to BCMA, there are also issues with existing 
systems.  Suboptimal BCMA design and implementation has resulted in medication 
administration workarounds.  A hospital located in southern New Hampshire, implemented a 
Knowledge Based Medication Administration (KBMA) system in January 2014.  Shortly after 
implementation, inefficiencies within the system were identified, resulting in KBMA nursing 
workarounds. 
The aim of this program evaluation quality improvement project using mixed methods 
was to identify the system’s issues, and processes resulting in workarounds to find solutions that 
optimize the KBMA system and ensure patient safety.  Override drug scan tracking reports were 
monitored for specific KBMA nurse workarounds during four phases from January 2014 to 
December 10, 2014.  Simultaneously structured observations of registered nurses using KBMA 
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(N = 52) were conducted over a three-month period.  System process changes and educational 
interventions were provided during the first three phases and withdrawn during the fourth phase.  
During the evaluation period, there was an overall decrease in KBMA workaround totals from 





Members of The Institute of Medicine (IOM) have estimated that patients are at risk for 
one medication administration error per day while hospitalized.  The IOM considers 
improvement in medication administration errors a priority patient-safety intervention.  With 
continued concern for potential medical errors, the IOM released a report in 2006, Preventing 
Medication Errors (IOM, 2006).  The report outlined approaches to error-prevention strategies 
for the healthcare industry in order to help decrease the incidence of medication errors.  One 
recommendation to aid in the reduction of medication administration errors is the use of 
barcoded medication administration (BCMA) systems (IOM, 2006). 	  
BCMA systems were developed to reduce medication administration errors and related 
expenses, ultimately in an effort to improve patient safety (Voshall, Piscotty, Lawerence, and 
Targosz, 2013).  By design, BCMA systems facilitate adherence to all aspects of patient 
medication rights, including right patient, drug, dose, route, and time (Wulff, Cummings, Marck, 
& Yurtseven, 2011).  At the same time, BCMA systems promote patient safety through 
awareness measures using prompts and alerts (National Patient Safety Foundation, 2013).  
Adverse drug events (ADEs) and resultant injuries increase hospital expenses.  
Depending upon facility size, annual hospital costs for all ADEs are estimated to be as much as 
$5.6 million per hospital.  Patients who experience ADEs have longer, and consequently more 
expensive hospitalizations than patients who do not suffer ADEs.  There is evidence that BCMA 
systems reduce ADEs, yet technology alone does not ensure the safe administration of 
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medication (Agency for Healthcare Research and Quality, 2012).  In a landmark study by Koppel 
et al. (2008), the authors developed a typology of 15 workarounds with 31 causes identified that 
interfere with the processes for the BCMA system.  Implementation and use of BCMA 
technology is solidly on the rise (Miller, Fortier, and Garrison, 2011) as it has become a criterion 
for achieving Stage 2 Core Measure 16 of Meaningful Use in hospitals starting in 2014 under the 
American Recovery and Reinvestment Act (Leung, 2012).  The American Recovery and 
Reinvestment Act of 2009 authorized the Centers for Medicare & Medicaid Services to award 
incentive payments to eligible hospitals who demonstrate Meaningful Use (MU) of a certified 
electronic health record (EHR).  Meaningful use sets specific objectives that hospitals must 
achieve to qualify for the incentives.  Implementation of BCMA technologies was part of Stage 2 
MU objectives of advanced clinical processes (Centers for Medicare and Medicaid Services, 
2014).	  
BCMA was first implemented in 1995 at the Veterans Medical Center in Topeka, KS, 
and was modified to meet the general requirements of all U.S. Veterans Health Administration 
(VHA) medical centers (Schneider, Bagloy, & Carlson, 2008).  Since then, BCMA systems have 
been implemented in hospitals across the United States in an effort to reduce medication 
administration errors.  Although there are different BCMA systems available, all BCMA systems 
require a sequence of steps to administer medications.  BCMA technology protocols require 
users to follow a series of procedural steps to administer medication.  BCMAs will detect 
mismatches between patient, medication, and the medication order with alerts and prompts.  
Users can either modify their actions according to the prompt or override the alert.  When an 
alert is overridden, a workaround has occurred (Koppel et al., 2008).  When users fail to use the 
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BCMA technology as intended through workarounds, medication errors can result (Patient 
Safety Advisory, 2008).  
Review of Evidence 
A systematic review of the literature was conducted of qualitative and quantitative, peer 
reviewed, research studies, and case studies that explored BCMA systems and nurse 
workarounds, published in English between 2008 through December 2014.  The time frame was 
selected, to include evidence published since the 2008 Koppel et al. review.  Reference lists from 
selected articles were reviewed.  Non-English and grey literature was excluded from the search. 	  
Exclusion Criteria 
Studies were excluded that researched automated dispensing machines, intravenous 
medication safety pumps, smart intravenous pumps, medication technicians, or settings outside 
an acute care hospital. 
Search Strategy 
The following databases were searched: CINAHL, Cochrane Database of Systematic 
Reviews, Medline, and ScienceDirect.  Key words for this search were: “barcode”, “medication 
administration technology”, “workarounds”, “nursing”.  Boolean Operators (and, or, not) were 
used to link key words.  Studies identified during the database search were retrieved based on 
information provided in the abstract or title. 
Data Extraction 
Data were collected and entered into spreadsheet for data management purposes.  Study 
variables included: title, author(s) of study, method, study setting, type of workaround, data 
analysis, results, recommendations, and level of quality (Appendix A). 
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Critical Appraisal 
All articles were assessed for methodological quality using the Joanna Briggs Institute’s 
(JBI) Qualitative Assessment and Review Instrument (QARI) (Appendix B).  The QARI 
Instrument is a 10-item checklist that examines components of validity, methodological 
appropriateness, and ethical conduct of the study (Briggs, 2013).  
Results 
Based on title or abstract, 21 publications were identified by the initial search strategy.  
After removal of duplicates, 13 of the publications were excluded with 8 deemed potentially 
eligible for review.  Of the 8 studies, three met inclusion criteria and were included in the review.  
Figure 1.1 Literature Search Flow Chart 













Synthesis of the Evidence 
The three studies reviewed described nurses in the acute care setting and identified 
workarounds associated with BCMA technologies.  The three research studies identified similar 
types of workarounds: omission of process steps, steps performed out of sequence, unauthorized 
process steps, technology related, task related, organizational related, patient and environmental 
related.  
 Miller, Fortier, and Garrison (2011) conducted an observational study looking 
specifically at high alert medication triggers and workarounds at a 709 bed academic medical 
center.  Seventeen percent of scanned medications triggered an error alert of which 55% were for 
high alert medications.  However, clinician override reasons for alerts were only documented for 
23% of the 55% of administrations.  The workarounds were divided into three categories: 
omission of a process step, performance of an unauthorized step, and performance of steps in 
improper sequence.  Over a 6-hour observation, 121 administration attempts were observed for a 
total of 468 different workarounds, averaging 3.8 workarounds per medication administration.  
All of the observed attempts included the workaround of scanning the medication outside of the 
patient’s room.  In addition, discrepancies included scanning a patient barcode identification 
bracelet that was not attached to the patient (90.1%), confirming administration before 
administration occurred (82.6%), and scanning medications for more than one patient at a time 
(46.3%).  
Rack, Dudjak, and Wolf (2011) used a mixed-method design, which consisted of staff 
nurse surveys, (n= 220), nurse focus groups (n= 43), and a medication error chart review (n=16) 
in a 765-bed academic medical center.  Staff nurse survey results revealed most staff nurses 
strongly agreed or agreed that BCMA systems enable them to administer medications safely 
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(n=199, 90%), medications administered to the right person (n=207, 95%), administered the 
correct dose (n=194, 88%), and administered the correct medication (n=200, 91%).  In addition, 
nurses were surveyed about their adherence to the medication administration policy.  Seventy-
eight percent of the nurses indicated that they followed the required process steps in the use of 
the hospital’s BCMA system.	  
Finally nurses were asked whether they encounter the following clinical situations when 
administering medications during their last shift: the need to administer medication without 
scanning the patient identification bracelet; administer medication without scanning the 
medication barcode; scan a medication package after the medications were administered; and 
place a patient identification bracelet on another object and scan it.  Sixty three percent (n=124) 
of staff nurses indicated the need to administer medications without scanning the patient 
identification bracelet, 72 percent (n=139) reported the need to administer the medication 
without scanning the medication barcode, 43 percent (n=76) reported that there was a need to 
scan the medication package after the medication was already administered, and 23 percent 
(n=43) had placed a patient identification bracelet on another object for scanning.   
Participants from the nurse focus groups in the Rack et al. study were asked to describe 
scenarios in their practice setting in which any of the four clinical situations previously 
mentioned would occur: the need to administer medication without scanning the patient 
identification bracelet; administer medication without scanning the medication barcode; scan a 
medication package after the medications were administered; and place a patient identification 
bracelet on another object and scan it.  Thirteen scenarios were identified in which there was a 
need to administer medications without scanning the patient; wristband failure (n=4), scanner 
failure (n=4), and BCMA use not expected because it was an emergency (n=5).  Eighteen 
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scenarios were described in which there was a need to administer medications without scanning 
the medication barcode; task too time consuming (n=6), barcode does not scan (n=6), scanner 
did not work (n=2), and BCMA use not expected because it was an emergency (n=4).  Two 
scenarios indicated the need to scan medication packages after the medications were 
administered  (n=2).  Lastly, 10 scenarios were identified related to scanning the patient 
identification bracelet that had been placed on another object, patient self removal (n=5), and 
identification bracelet did not fit over patient limbs, casts, or bandages (n=5).   
Yang, Kankanhalli, and Yip (2011) used a qualitative case study approach in a large 
public hospital with over 900 beds.  Two researchers conducted interviews with a variety of 
personnel (n=30), including eleven nurses.  Once the workarounds and the issues causing the 
workarounds were identified, the authors assigned them into categories: technology related 
(n=5), task related (n=5), organizational related (n=3), and augmented work (n=3).  
Workarounds specifically performed by nurses included: nurse used a computer on wheels 
(COW) instead of the required personal digital assistant (PDA) to administer the medication, 
nurses picked the next administration time slot to administer the medication because the current 
slot was used (already signed out), nurses used a PDA to scan the patients identification bracelet 
on a clinical clipboard instead of scanning the patient identification bracelet that was on the 
patients wrist, nurses administered medication outside of the expected timing, nurses cleared 
omission for PRN medications in batches, nurses clicked on the medication to be administered in 
the MAR before administering, nurse did not administer the medication according to the order in 
Electronic Medication Administration System (EMAS), nurse co-signed for another nurse during 
medication administration, and nurses administered medications before it was ordered.  
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Yang et al. identified four workarounds similar to those in the Koppel et al. review.  
However, five new workarounds were identified: the nurse picked the next time slot to 
administer the medication, the nurse cleared omission for PRN medications in batches, nurses 
co-signed for one another during medication administration (entering another nurse’s password 
without the second nurse actually being present), the nurse did not administer the medication 
according to the order, and nurses administered medications outside of the prescribed time 
frame. 
 The first new workaround described occurred when the nurse cleared omission for PRN 
medications in batches in response to unnecessary alerts for PRN medications.  If nurses do not 
provide a reason why the patient does not need the PRN medication, the order will be reported as 
an omission and be overdue in the EMAS.  Therefore, the nurse clears all the omissions in 
batches.	  
 The second type of new workaround described the nurse not administering the 
medication according to the order in the EMAS.  Due to different unit practices and stringent 
EMAS order sets, the nurse selected to omit the administration because the volume of 
intravenous fluids ordered was too large for the pediatric patient.  
Koppel et al. (2008) described a user bypass for a double check.  The second nurse would 
confirm the double check without reviewing the medications.  Yang et al. (2012) described the 
third new workaround: nurses cosigned for another nurse by entering in a colleague’s password 
without the colleague being present.  The nurses felt the cosigning process was too cumbersome.   
The fourth new workaround described nurses administering medications outside of the 
prescribed time frame.  “Sometimes we have this medicine that should be served before meals 
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but doctor order says to be served at 8pm.  So what we do is that we serve before meal but justify 
it accordingly as an early serving”  (Yang et al. 2012, p. 55).  In the fifth new workaround, 
nurses unfamiliar with the EMAS selected the next prescribed time frame to administer a 
medication that was overdue.  Providers would then have to enter an additional dose to correct 
the error. 
EMAS were developed with the intention of improving patient safety, however new 
workarounds have been identified in the literature.  It is apparent that EMAS/BCMA systems 
continue to be used incorrectly, limiting their intended patient safety benefits.  Solutions for the 
identified workarounds need to be implemented to eliminate unsafe practices and potential for 
patient harm.	  
The many existing BCMA workarounds are well known, yet new forms of BCMA 
workarounds continue to emerge.  A few topics are worthy of further discussion, such as 
considering whether all workarounds are unsafe or are they inherent systems issues, can these 
systems issues be truly eradicated, and whether there are acceptable circumstances that justify 
the workaround.  Finally, processes need to be standardized that optimize the use of the system.  
For example, the literature shows that BCMA workarounds can occur due to system-related 
problems, beyond the control of the initiating nurse.  A nurse, who is unable to scan a medication 
barcode because the battery is low on the scanner, or the barcode is unreadable, is not at fault.  
The nurse must work around the problem to administer required medication.  Sometimes nurses 
used clinical judgment in effort to avoid harm to their patient, such as in the case in the Yang et 
al. study, in which the nurse knew that the prescribed intravenous medication would cause harm 
to the pediatric patient. 	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There can be circumstances when BCMA workarounds are unavoidable.  One situation to 
consider is that of an emergency.  The logistics of the BCMA medication administration 
protocols during an emergency can be impractical.  Finding solutions to correct the system-level 
problems takes leadership.  Solutions require leaders at all levels of the healthcare organization 
employing BCMA systems, include the end user to understand the nature and frequency of 
BCMA workaround occurrences, and optimize the system in an effort to ensure that every 
patient receives the safest possible care.  Leading requires taking action while being vigilant 
about how current processes are failing.  For example, in each of the three studies, unreadable, 
unscannable patient barcode identification bracelets contributed to a workaround.  New 
technologies may provide alternative solutions.  	  
Lanoue and Still (2008) determined that linear barcodes are more difficult to scan than 2-
D barcodes.  Due to the length of linear barcodes, the curvature of the patient's wristband distorts 
the spacing of the barcode making it difficult to scan.  After several unsuccessful scanning 
attempts, nurses override the BCMA system, and select ‘unreadable barcode’ as an option to 
continue with the medication administration process.  It is critical to confirm patient 
identification, and omission of this step puts patients at greater risk for error. 
2-D barcodes offer an alternative solution to the linear barcode design.  2-D barcodes 
encode more data in a smaller space, are readable from any direction, can be repeated around the 
length of the wristband, and offer greater read-accuracy (Lanoue & Still, 2008).  2-D barcodes 





 The global aim of this quality improvement project was to improve medication 
administration safety through efficiency advancements to optimize the barcode-scanning 
technologies. 
Problem Statement 
Knowledge-Based Medication Administration (KBMA) at the hospital was implemented 
in January 2014.  Implementation inefficiencies within the system were identified resulting in 
KBMA nursing workarounds.  The specific aim of this project was to identify the types and 
causes of the nurse workarounds to help find solutions to optimize the KBMA system to provide 
and ensure patient safety.  The process began with identifying and correcting KBMA related 
inefficiencies, and ended with a decrease in the overall total of KBMA nursing workarounds 
from date of implementation through September 30, 2014, and meet Meaningful Use Stage 2 
Core Measure 16 during the Attestation period of July 1, 2014 through September 30, 2014.  
Conceptual Model	  
Hospitals are complex adaptive systems consisting of a large number of interactive 
subsystems.  Most errors and inefficiencies in patient care, result from suboptimal systems of 
which they are a part and with which they interact.  To improve the design of these systems, the 
IOM has proposed the application of engineering concepts and methods in particular, human 
factors and systems re-engineering (Crayon, Hundt, Karsh, Gurses, Alvarado, Brennan, 2006).  
Emphasis on system design was recommended in a recent report by the National Academy of 
Engineering and the IOM: “…it is time to establish a vigorous new partnership between 
engineering and health care and hasten a transition to a patient-centered 21st century health care 
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system” (Reid, Compton, Grossman, & Fanning, 2005, p. 15).  Patient safety researchers 
recognize the need for human factor engineering and system approaches to safety research, 
analysis, and improvement (Crayon et al., 2006).   
The Systems Engineering in Patient Safety (SEIPS) model of work system and patient 
safety (Figure 1.2) provides a framework for understanding relationships among the structures, 
processes and outcomes in health care.  The SEIPS engineering approach to patient safety is 
anchored within the industrial engineering subspecialty of human factors.  The discipline of 
human factors emphasizes interactions between people and their environment that contribute to 
performance, safety and health, quality of working life, and the goods or services provided.  The 
SEIPS model explains how the design of the work system can impact not only the safety of 
patients but also employee and organizational outcomes.  It is important to characterize these 
many interactions between people and their environment in a concise and articulate manner to 
identify points for improvement or intervention (Carayon, Wetterneck, Rodriguez, Hundt, 
Hoonakker, Holden, Gurses, 2013).  
Work systems need to be well designed for optimal performance.  When system designs 
are suboptimal poor processes and outcomes may occur, triggering an intervention or system 
redesign.  Within the health care system, redesign begins with the identification of the negative 
work system elements including employee and organizational outcomes that affect quality and 
safety of care (Carayon et al., 2006).   
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Ethical consideration for the protection of human subjects was submitted to the 
University of New Hampshire’s Institutional Review Board.  The application was withdrawn as 
the proposed program evaluation was deemed quality improvement and not research.  (Appendix 
C).  
Project Design 
A repeated measures mixed methods program evaluation was conducted to identify the 
types and causes of KBMA nurse workarounds occurring at the hospital from January 10, 2104 
to December 10, 2014.  A Logic Model (Figure 2.1) was developed to depict relationships 





Figure 2.1 KBMA Evaluation Logic Model 
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The process begins with understanding the KBMA Process and ends with an optimized 
system that meets organizational Meaningful Use measures.  A nurse is required to follow a 
sequence of steps in order to ensure safe medication administration.  If any step in the process 
sequence is not met, the nurse should stop the medication administration and correct the error 
(Figure 2.2).  
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Figure 2.2 KBMA Process 
 
Phase 1: January 2014 through March 2014 
A KBMA Optimization Committee was established which included key stakeholders 
from the following departments: pharmacy, information technology (IT), respiratory therapy, 
directors from each inpatient unit, nurse researcher, quality improvement, clinical education 
specialists, and manager of nursing systems and support.  In the preplanning stages of KBMA, 
the committee completed a KBMA assessment report.  The report provided insight into current 
strengths and weaknesses of all processes involved with medication administration at the hospital 
(Appendix D).  The pharmacy team continued to acclimate themselves to KBMA software by 
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training in a testing playground.  New barcoding and repackaging equipment was tested, and 
over 1800 formulary medications were entered into the new system.  Fine tuning all pharmacy 
work processes occurred during this phase. 
IT worked closely with pharmacy and the manager of system support for nursing.  
Electronic Administration Record (eMAR) screens were altered based on pharmacy and/or 
nursing needs.  Computer on wheels, scanners, and fixed devices (computers) in patient rooms 
were installed and tested. 
KBMA training for end users and super users continued through Phase 1.  End users 
included: nurses, respiratory therapy, unit directors, IT support, and pharmacy team.  Super-users 
received extra training and provided additional technical support once KBMA implementation 
went live on each of the units.  In March, KBMA was piloted on one medical surgical unit.  
KBMA related issues that arose on the medical surgical unit during the pilot period were 
addressed on a moment-to-moment basis when possible.  If the problem could not be resolved 
immediately, the appropriate department was notified.  For example, if the problem were 
technology related, IT would consult with the nurse having process issues, or go directly to the 
equipment to resolve the issue. 	  
From the onset, nurse workarounds were identified as a potential problem in relation to 
KBMA compliance.  Baseline data for phase 1 was obtained by KBMA tracking reports.  The 
reports informed the work of the KBMA Optimization Committee with a variety of data 
including nurse drug scan overrides, which are considered unsafe workarounds.  All KBMA 
related problems identified during the pilot implementation were discussed with the KBMA 
Optimization Committee in the scheduled weekly meetings.  	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Phase 2:  April 2014 through June 2014 
Phase 2 began with the implementation of KBMA on ten inpatient units.  Not all ten units 
went live at the same time.  Instead, a staged KBMA roll out over a two-month period occurred.  
Weekly KBMA Optimization Committee meetings continued throughout Phase 2.  As more units 
went live with KBMA, increases in the number of nurse workarounds were identified.  Each 
member of the Optimization Committee reviewed override drug scan reports weekly.  Reviewing 
the reports in detail provided committee members the opportunity to understand unit-specific 
issues and precisely what types of workarounds were occurring.  Data on care processes and 
organizational outcomes were used to identify problems and provide opportunities to assist with 
finding solutions to the processes at fault in the work system, this is a key feature of the feedback 
loops in the SEIPS model.	  
There were still areas on certain units and patient rooms where the wireless data 
communication connectivity required for KBMA use was poor.  The nurses were either unable to 
connect to the eMAR or in instances when the nurses were able to connect the signaled dropped 
during the KBMA process.  Nurses also reported problems with the scanners not working.  After 
evaluating the problem, it was revealed that the scanners were not being docked properly after 
use.  In addition, many nurses were unaware of how to reset (reboot) the scanner when the 
scanner was not working correctly.  Reeducation was provided to nurses either 1:1, via 
postings/alerts in medication rooms, or email updates.  . 	  
Nurses described trouble-scanning barcodes on medications that were dispensed in tubes 
such as ointments or lotions.  If the tubes were crimped from squeezing, the barcode would not 
scan or if the tube had any residual medication on the barcode it would not scan, even after 
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attempts were made to wipe off the medication.  The committee decided to trial placing barcodes 
near the top of the tubes and off to the side.	  
Licensed Nursing Assistants (LNA’s) are permitted within their scope of practice to 
apply specific lotions on a patient, i.e. skin barriers.  Typically, the application is scheduled and 
applied during AM care and throughout the day as needed.  If the nurse were not available to 
provide the LNA with the lotion at the time of care, an alert would populate in the eMAR 
indicating a late administration.  Late or early medication administration is considered a 
workaround.  Every patient room was provided a lock-box for LNA type lotions so that the 
LNA’s were not dependent on the nurse for retrieving lotions. 	  
Damaging barcodes when removing specific doses of medication from a sheet of 
medications was another instance that nurses were struggling with.  Certain packaging had a foil 
component to it, or the packaging was thick, and when the nurse attempted to rip off the required 
dose, the barcodes were damaged in the process.  Every medication room on each unit was 
supplied with scissors just for this instance. 	  
Phase 3:  July 2014 through September 2014 
In addition to resolving ongoing workaround issues, primarily IT and pharmacy related, 
Phase 3 began at the hospital with the MU Attestation period from July 2014 through September 
30, 2014.  During this time, data was collected on the number of medications from order to 
administration using the KBMA system.  The metric set for The hospital to meet the MU Stage 2 
Core Measure 16 specified that more than 10 percent of medication orders created by providers 
had to be tracked using the eMAR.  The attestation requirements were calculated using the 
following Denominator/Numerator/Threshold/Exclusion criteria: 
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• Denominator: Number of medication orders created by authorized providers in the 
eligible Critical Access Hospital (CAH) inpatient departments during the Electronic 
Health Record (EHR) reporting period. 
• Numerator: The number of orders in the denominator for which all doses are tracked 
using the eMAR. 
• Threshold: The resulting percentage must be more than 10 percent in order for an eligible 
CAH to meet this measure. 
• Exclusion: Any eligible CAH with an average daily inpatient census of fewer than 10 
patients. 
Phase 4: October through December15, 2014 
At the end of the attestation period, over sight by the KBMA optimization committee was 
withdrawn and data collected to evaluate the sustainability of the system changes.  The 
optimization committee continued to collect data but did not meet to review data or make further 
changes to the system.  
Data Sources 
1. A review of the KBMA Readiness Assessment Report was conducted to understand the 
implications associated with the planning process required for implementation of the 
KBMA system.  The 15 page report covered the following topics: eMAR, Nursing, 
Staffing, Pharmacy Team, Automatic Dispensing Machine, Compounding System, 
Repackager, Purchasing of Bar Code Medications, Labeling, Formulary Floor Stock 
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Medications, Route Code Medications, Medication Order Flow, and Test Environment 
(Appendix E). 
2. The KBMA Optimization Committee created the anticipated KBMA Override Reasons 
(Category 1) built into the system based on the following: discussions with the BCMA 
vendor and pharmacy directors, problems that were identified during the KBMA 
educational training sessions, and issues that arose during the KBMA implementation 
pilot.  This category acknowledges system issues that could be tolerated due to the 
structure of KBMA and could not be corrected by optimization.	  
Override drug scan coded reason tracking reports were analyzed from January 10, 2014 
to December 10, 2014.  The reports provided the total number of override drug scans for 
each of the KBMA administration override reasons presented in Table 2.1.  For example, 
the week of June 16th there were 83 overrides under the category ‘Barcode Damaged 
When Opening Package’, and 50 under the category ‘Barcode Missing’.  All drug scan 
coded reason totals were entered into a spreadsheet in weekly increments, and results 
were presented at the weekly Optimization Committee meetings.	  
Table 2.1 Knowledge-Based Medication Administration Override Reasons 
LNA/RN Not Trained on KBMA 
Rate Change/Rate Check/End Shift Total 
Barcode Damaged When Opening Package 
Patient’s Own Medication 
Barcode Damaged/Unreadable, No Other Package 
Barcode Missing 





Order Changed.  Label Barcode is Old Order Number 
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KBMA Coded Reason Definitions 
1. LNA/RN Not Trained on KBMA 
• Licensed Nursing Assistant/ Registered Nurse not trained on KBMA system 
2. Rate Change/Rate Check/End of Shift Total 
• Registered nurse will scan all rate changes (increase/decrease) on all the following 
intravenous drips: continuous medicated solutions, total parenteral solution, patient-
controlled analgesic, epidurals, heparin, and insulin 
• Registered nurse will scan intravenous drip(s) to verify correct rate(s) 
• Registered nurse will scan all intravenous drips at end of shift to obtain total volume 
infused 
3. Barcode Damaged When Opening Package 
• Barcode damaged when opening package (ripped, torn, split, crumpled) 
4. Patient’s Own Medications 
• A patient own medication will be pharmacy approved and identified only if presented in 
their original labeled container.  Registered nurse will send patient own medications to 
pharmacy for verification.  Pharmacy will place a verification sticker after positive 
identification.  No barcode will be placed on patient own medications to scan through 
KBMA.  However, the registered nurse must go through KBMA, select No Scan and then 
select ‘Patient Own Medication’ from drop down menu. 
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5. Barcode Damaged/Unreadable.  No Other Package 
• Barcode on medication packet is damaged and therefore unreadable and unscannable 
• No other medication packet was available to replace damaged medication packet 
6. Barcode Missing 
• Barcode missing on medication (auxiliary label missing or is covering up barcode on 
medication) 
7. Product Not Found 
• Registered nurse scanned wrong barcode or pharmacy did not link medication to stock 
item level in Sunrise 
8. PACU Titration 
• Post Anesthesia Care Unit registered nurses will scan intravenous drip medication(s) 
when first drawn up and or administered to the patient  
9. Scanner Inoperable 
• KBMA handheld scanner inoperable  
10. Pyxis Override 
• Pharmacy has not yet verified medication and registered nurse overrides Pyxis alert (e.g. 
STAT medication) 
11. Downtime Recovery 
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• KBMA system down and unavailable thus to update KBMA software 
12. Order Changed.  Label Barcode is Old Order Number 
• Provider changed order and medication scanned is an old order number 
3.  Override drug scan free text reason tracking reports those workarounds noted by nurses that 
were not anticipated to be systems issues (category 1).  These reports were analyzed from 
January 10, 2014 to December 10, 2014.  This was identified as the second override drug scan 
category (category 2).  The free text reasons that met criteria in this category were coded and 
assigned to one of the KBMA administration override reasons, i.e. if the nurse wrote  “ barcode 
would not scan”, the reason was coded under ‘Barcode Damaged/Unreadable, No Other Package 
Available’.  When a free text reason could not be assigned a new domain was established 
(Category 3).  In total, 21 domains were established (Table 2.2).	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Done By Other 
Bracelet Not Scanning 
No Medication Given 
Infusing As Ordered 
Computer/Technical Issues 
CMO 
Medication Was Scanned 




Not Verified From Pharmacy 
Override Dose 
Duplicate 
Did Not Carry Over 
Task Box Missing 
Blood Products 
 
4.  Observations of registered nurses (RN’s) during medication administrations on inpatient units 
were conducted to corroborate the data being reported on the KBMA override log reports.  
Inpatient units included: medical surgical, rehab, cardiac care, intensive care, and post anesthesia 
care.  Observations occurred on a variety of shifts: 7:00am-3:00pm, 3:00pm -11:00pm, 7:00am- 
7:00pm, 7:00pm-7:00am.  The data collected involved unambiguous measurement that did not 
require subjective judgment.  To ensure consistency of observations, the evaluator created an 





Table 2.3 Observational Tool 
Inpatient Unit Type (e.g. Med-Surg)  
Total # of Medication Administered  
Wait Time for Pyxis (Y/N)  
High Alert Medication  
1. Independent Double Verification 
(Y/N) 
2. Syringe labeled (if applicable) 
(Y/N) 
 





Override drug scan free text reason tracking reports were analyzed from January 10, 2014 
to December 10, 2014.  A total of 10,475 free text override reasons were hand-coded.  From that 
total, 2,793 free text reasons were assigned to Category 2, meaning the free text reason the RN 
provided matched one of the established KBMA administration override reasons established as 
anticipated systems issues.  Category 2 had the same 12 domains as Category 1.  By not using 
the category 1 override reason; the nurses were not using proper processes.  The remaining 7,682 
free text override reasons were designated to Category 3, which resulted in 21 new domains of 
KBMA nurse workarounds considered both system and process issues. 	  
Descriptive Statistics 




Phase 1 had the fewest medications scanned per that time period (N = 159, 250) however, 
Category 1 (N = 8,425) had the highest override totals out of Phases 1-4.  Total override scans 
for Phase 1 were (N = 12, 231). 
Table 3.2  Phase 2 April through June 
 
 
Phase 2 had the most medications (N = 261, 729) though each category had fewer 
override scan totals when compared to Phase 1.  Total override scans for Phase 2 were (N = 




Table 3.3 Phase 3 July through September 
 
 
Phase 3 had fewer medications scanned (N = 256,851) when compared to Phase 2 and 
each category totals decreased significantly when compared to both Phase 1 and 2 reflecting 
system optimization.  Total override scans for Phase 3 were (N = 7, 494) indicating a significant 
decrease in override scan workarounds by (N = 4, 737) when compared to Phase 1 and when 
compared to Phase 2  (N =3, 477). 
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Table 3.4 Phase 4 October through December 
 
 
Phase 4 had the second fewest number of medications scanned of all four Phases (N = 
215,596) and each category decreased significantly when compared to Phases 1 -3 indicating 
system optimization.  Total override scans for Phase 4 were,  (N = 5, 321) demonstrating a 




Table 3.5 Category1 Override Scans Comparison-Counts by Month 
Jan Feb Mar Apr May June July Aug Sept Oct Nov Dec
 Rate change/Rate check/End shift total 335 922 942 752 369 317 242 252 360 311 228 74
 Barcode Damaged when opening package 125 553 662 559 327 307 336 242 252 324 313 69
 Barcode Damaged/Unreadable. No other package available 58 512 653 431 332 279 236 190 228 260 290 84
 LNA/RN not trained on KBMA 42 517 233 277 402 398 383 302 189 156 63 17
 Patients Own Medication 3 243 355 337 390 244 126 114 215 131 119 63
 Barcode Missing 49 299 406 324 226 157 105 82 153 136 122 35
 Scanner inoperable. 49 205 288 192 94 93 76 79 113 86 63 18
 Product Not Found 110 199 147 129 96 81 62 85 58 52 58 7
 Downtime Recovery 3 182 78 115 76 96 266 5 6 15 10 0
 PACU Titration 0 0 32 93 132 108 119 137 166 213 120 61
 Pyxis Override 6 80 91 94 92 39 63 52 83 78 56 31




Rate Change/Rate Check/End Shift Total domain had the highest overall total (N = 
5,104).  However, over the four Phases the totals dropped significantly.  Phase 1 (N = 2,199), 
Phase 2 (N = 1,438), Phase 3 (N = 854), Phase 4 (N = 613). 
Barcode Damaged When Opening domain had the second highest overall totals (N = 
4,069).  The totals did decrease over the Phases but not as dramatically seen in the Rate 
Change/Rate Check/End Shift Total domain.  Phase 1 (N = 1,340), Phase 2 (N = 1,193), Phase 3 
(N = 830), Phase 4 (N = 706). 
The third highest over totals were for the Barcode Damaged/Unreadable.  No Other 
Package Available domain (N = 3,553).  Totals decreased by half in Phase 3 and 4.  Phase 1 (N = 
1,223), Phase 2 (N = 1,042), Phase 3 (N = 654), Phase 4 (N = 634). 
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The following four domains all had totals ranging between 2, 979 – 2, 034: LNA/RN Not 
Trained On KBMA (N = 2,979), Patient Own Medication (N = 2,340), Barcode Missing (N = 2, 
094), and PACU Titration (N = 2,034). 
Of the remaining five domains Scanner Inoperable had the highest total (N = 1,356).  
Label Barcode Is Old Order had the least overall total (N = 165). 
Category 2 Override Scans Comparison 
Table 3.6 Category 2 Override Scans Comparison-Counts by Month 
Jan Feb Mar Apr May June July Aug Sept Oct Nov Dec
1	  Rate	  Check 94 88 40 23 14 25 15 10 21 15 20 1
2	  Barcode	  Damaged	  when	  opening	  package 0 0 0 0 0 0 0 0 0 0 0 0
3	  Barcode	  Damaged/Unreadable.	  No	  other	  package	  available 78 150 255 152 85 91 84 78 77 83 76 17
4	  LNA/RN	  not	  trained	  on	  KBMA 9 13 3 6 9 7 6 7 3 7 3 0
5	  Patients	  Own	  Medication 6 26 33 50 21 10 15 8 7 9 4 0
6	  Barcode	  Missing 29 39 33 52 30 18 12 15 20 23 16 1
7	  Scanner	  inoperable 20 22 36 22 10 15 14 4 49 14 20 11
8	  Product	  Not	  Found 3 15 5 10 4 14 9 1 7 2 2 0
9	  Downtime	  Recovery 0 0 0 0 0 0 0 0 0 0 0 0
10	  PACU	  Titration 0 0 0 0 0 0 0 0 0 0 0 0
11	  Pyxis	  Override 0 0 0 0 0 0 0 0 0 0 0 0
12	  Order	  changed.Label	  Barcode	  is	  old	  order	  number 12 33 38 39 38 27 26 26 33 44 20 6
Counts by Month
 
Barcode Damaged/Unreadable, No Other Package domain had the highest overall total 
for all four Phases (N = 1,226).  Phase 1 the largest (N = 483), Phase 2 (N = 328), Phase 3 (N = 
239,) and Phase 4 had the least (N = 176).  Example free text reasons included, “ barcode will 
not scan”, tried 3 times can’t scan”, “multiple attempts scanning won’t scan”. 
Rate Change/Rate Check/End Shift Total reason was the second highest in regards to 
total overrides for Category 1 for all four Phases (N = 366).  Phase 1 had the most (N = 222), 
Phase 2 (N = 62), Phase 3 (N = 46) and Phase 4 the least (N = 36).  Example of free text reasons 
for this domain included, “checking end of shift total”, and “no rate change”, “checking rate”. 
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Barcode Missing domain overall sums were (N = 288).  Both Phase 1 and 2 totals were 
(N = 100), in Phase 3 and 4 the totals dropped by half (N = 47) (N= 40). 
LNA/RN Not Trained on KBMA (N = 73) and Product Not Found (N = 72) were close in 
value for overall totals.   
Patient’s Own Medication domain totals were (N = 189).  Phase 1 (N = 65), Phase totals 
increased to (N = 81), then decreased in Phase 3 to (N = 30) and ultimately decreased further in 
Phase 4 to (N = 13).  Example free text reasons included, “pt brought meds in from home”, “ 
home meds”. 
Scanner Inoperable domain sums were (N = 237).  Phase 1 (N = 78), Phase 2 decreased 
to (N = 47) then increase in Phase 3 (N =67), then decreased again in Phase 4 (N =45).  Example 
free text reasons included, “ scanner won’t work”, “scanner issues”, “IT notified scanner isn’t 
working”. 
The following domains all had (N = 0) for all four Phases:  Barcode Damaged When 
Opening Package, Downtime Recovery, PACU Titration, and Pyxis Override. 
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Category 3 Override Scans Comparison 
Table 3.7 Category 3 Override Scans Comparison/Counts by Month 
Jan Feb Mar Apr May June July Aug Sept Oct Nov Dec
Insulin 220 221 177 114 86 88 60 29 30 26 21 10
User	  Error 43 271 278 296 164 129 140 110 203 190 202 59
Procedural	  medications 19 59 49 87 66 44 60 41 51 52 35 9
STAT 7 55 60 58 28 31 33 30 35 30 25 7
Done	  by	  other 21 78 68 54 64 58 35 48 52 39 68 10
Bracelet	  not	  scanning 25 20 24 9 5 7 4 12 4 4 4 1
No	  medication	  given 34 42 54 52 37 32 19 19 21 18 33 14
Infusing	  as	  ordered 38 19 8 19 5 4 4 3 3 0 1 0
Computer/technical	  issues 2 21 25 16 10 45 37 10 25 26 13 2
CMO(comfort	  measure	  only) 4 1 23 3 6 13 3 25 7 0 4 1
Medication	  was	  scanned 19 42 50 35 21 27 18 29 39 42 39 16
Repeate	  dose/partial	  dose 12 38 48 45 25 14 30 12 21 23 19 6
Late	  adminsitraion/Early	  administration 22 131 123 73 50 31 26 38 36 48 33 9
Patient	  related 0 17 22 19 13 9 3 6 6 13 7 0
Clinical	  judgement 3 15 3 7 0 1 0 3 0 2 0 0
Not	  verified	  from	  pharmacy 3 19 6 7 3 5 3 1 3 2 0 0
Override	  dose 4 23 35 30 19 8 13 21 12 15 16 2
Duplicate 1 5 7 6 4 1 4 5 1 2 1 1
Did	  not	  carry	  over 5 22 13 34 5 7 1 10 14 5 4 0
Task	  box	  Missing 14 20 16 14 10 7 11 6 4 8 4 1
Blood	  Product 0 2 1 5 5 5 3 3 2 1 5 2
50%	  dose 1 2 16 6 1 2 0 0 0 3 1 1
Not	  in	  a	  Category 28 70 73 52 48 37 28 39 31 43 40 10
Counts by Month
 
The User Error domain had the highest overall total out of all 21 domains and the highest 
for all four Phases (N = 2,085) and stayed consistently high over each of the four Phases: Phase 1 
(N = 592), Phase 2 (N = 589), Phase 3 (N = 453), and Phase 4 (N = 451).  Example free text 
reasons, “I accidentally forgot to scan”, I forgot to use KBMA process, and “I threw out vial 
before scanning”.	  
The second highest overall total domain was Insulin (N = 1, 082).  However, unlike the 
User Error domain the Insulin totals decreased significantly over the four phases: Phase 1 (N = 
618), Phase 2 (N = 288), Phase 3 (N = 119), Phase 4 (N = 57).  Example free text reasons, “no 
insulin needed”, and “marked off zero insulin”. 
The third highest overall total domain was Done By Other (N = 994).  The totals 
remained relatively consistent for Phases 1-3.  Phase 1 (N = 167), Phase 2 (N = 176), Phase 3 (N 
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= 135) and then decreased slightly for Phase 4 (N = 117).  Example free text reasons, “ given by 
Jane on previous shift”, “given by MD”, and “administered by PA”. 
Late/Early Administration had the fourth highest overall totals (N = 620) however, by 
Phase 4 totals decreased significantly.  Phase 1 (N = 276), Phase 2 (N = 154), Phase 3 (N = 100), 
and Phase 4 (N = 90).  Example free text reasons, “given late”, and “administered early per MD, 
“given early prior to testing”. 
Procedural Medication was fifth highest in overall totals (N =572).  Phase 1 (N = 127), 
Phase 2 had an increase (N = 197), Phase 3 (N = 152), and Phase 4 decreased to (N = 96).  
Example free text reasons, “given during OR procedure”, “ procedure med”, and “given prior to 
procedure”. 
The remaining 16 domains had overall totals ranging from 399 – 33.  The domains with 
the least override totals were Patient Related (N = 34), Task Box Missing (N = 34) and Blood 
Product (N = 33). 
Hypothesis Testing  
Based on the specific aim of this evaluation, it was hypothesized that by optimizing the 
KBMA system and correcting process issues there would be a decrease number of workarounds 





Table 3.8 KBMA Phase Total Overrides by Category	  
 
 
Phase 1 and Phase 3 are significantly different as are Phase 1 and Phase 4.  This would 
indicate that optimizations and education in Phase 1 improved the systems and processes of 
KBMA for Phase 3 and 4, but there were no significant changes in workarounds based on 
changes made in Phase 2. 
Table 3.9 KBMA Categorical Total Overrides for 2014 
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 Category 1 override workarounds decreased significantly from April through June and 
again in mid November through December.  The increase seen in August through mid November 
indicates optimization and education was not effective during this time period.  Category 2 
override workarounds did not decrease until May and then increased slightly in September 
through October.  The trends in this category are very similar to those found in Category 1. 
Category 3 had similar trends as seen in both Category 1 and 2 except for the significant 
decrease in March, indicating education and optimization during the KBMA pilot period was 
effective. 
Table 3.10 KBMA Total Overrides for all Categories Combined 
 
 Total override workarounds for all combined categories decreased significantly from 
Phase 1 to Phase 4, indicating education and optimization ultimately improved systems and 
processes of KBMA. 
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MU KBMA Compliance Monthly Averages	  
Table 3.11 July through September Meaningful Use KBMA Compliance Percentage Averages 




37.05% 37.52% 39.74% 
MU KBMA % 
Compliance Goal 
10% 10% 10% 
  
Table 3.16 shows MU KBMA compliance goals were met each month during the MU 
attestation period. 
Structured Observations 
Structured observations of RN’s using KBMA were conducted over a three-month period 
on the following inpatient units: medical surgical, rehabilitation, cardiac care, intensive care, and 
post anesthesia care  (N = 52).  Observations were conducted on a variety of shifts: 7:00 a.m. - 
3:00 p.m., 3:00 p.m. -11:00 p.m., 7:00 a.m.- 7:00 p.m., 7:00 p.m. -7:00 a.m.  A total of (N = 191) 
medications were administered during the observational period.  The total number of 
workarounds (N = 22) occurred during the structured observations.   
Patient Identifiers 
The largest number of workarounds fell in patient identification.  Twelve RN’s did not 
ask their patient’s to state their name and date of birth prior to scanning their patient 
identification bracelet.  All of the patients were alert and oriented and would have been able to 
answer the questions if asked. 
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Two different patient identification bracelets would not scan during the administration 
process.  The correct procedure is to identify the patient’s name, date of birth, and medical 
record number against the patient’s eMAR.  In both instances, the RN did not follow the correct 
process as defined by policy.	  
Insulin Administration 
Administering insulin requires an independent double verification that requires the RN to 
pull up the correct amount of insulin into an insulin syringe based upon the patient’s blood 
glucose and medication order.  There is an insulin sliding scale order that the RN verifies how 
much insulin to administer.  For example, if the patient’s blood glucose were 160 the insulin 
sliding scale order would state to administer two units of insulin for blood glucose of 150-170.  
The second RN verifying the insulin dose should independently look at the patient’s blood 
glucose, independently check the insulin sliding scale order, and then verify the amount of 
insulin drawn into the syringe.  The administering RN places a barcode sticker on the insulin 
syringe for the barcode scanning process.	  
In one observation the RN administered insulin without any verification from another 
RN, and during another observation the second RN did not perform any independent verification.  
Instead the second RN glanced at the insulin syringe and nodded her head suggesting it was safe 
to administer. 
Non-formulary Medications 
In three different observations the RN was unsure of the KBMA process for 
administering non-formulary medications.  In all three instances the patient brought in their own 
medications.  The medications were verified by pharmacy however; the pharmacy’s policy does 
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not require a barcode to be placed on the patient’s medication container.  The proper process is to 
go through KBMA and select No Scan and then select ‘Patient Own Medication’ from the drop 
down menu.  Instead all three RN’s omitted the KBMA process altogether and administer it 
through the eMAR. 
Early Medication administration 
 Four observations exposed RN’s administering medications early.  One occurrence was 
per patient request.  The patient regularly took the medication at 5:00 p.m. at home; it was 
prescribed to be administered at 7:00 p.m. per the medication order.  The correct process would 
have been for the RN to notify the pharmacy to change the time on the order to 5:00 p.m.; 
however, the RN did not follow through with pharmacy.  The remaining three early 
administrations involved a nasal spray, an ointment, and an eye drop.  All were scheduled to be 
administered at 10:00 a.m. however all three RN’s administered the medications during their 
8:00 a.m. medication pass. 
Medication Packaging 
Some oral medications are not packaged separately but instead are attached together in a 
multi-dose packet.  The RN tears off however many pills is needed per the medication order.  
Most often the RN will leave the pill packaging attached if more then one is selected.  For 
example, the medication order is for Tylenol 650 mg.  The Tylenol is packaged in 325 mg 
tablets; the RN tore off two tablets, however the packages remain attached.  The correct process 
is to scan each tablet (package) separately, yet during three different observations the RN 




The results of this program evaluation revealed that the hospital met MU Stage 2, and 
KBMA overall workaround totals decreased from Phase 1 to Phase 4.  The cause and types of the 
KBMA workarounds discovered were similar to those found in the literature.  Understanding 
why the workarounds occurred could be explained by variables identified in the SEIPS Model: 
technology and tools, organization (KBMA policy and procedures, person (nurse), tasks 
(medication administration), and environment (medication rooms, workstations, and patient 
rooms).  Given the complexity of healthcare it is crucial for organizations to understand their 
work systems and the impact (workarounds) it has on patient safety.  	  
 Nurses developed workaround strategies when faced with obstacles using KBMA.  
Resolutions that do not consider issues across the whole system, including organizational factors 
are unlikely to have significant or sustainable impact.  Although the attributes are described 
separately, it is important to emphasize the importance of the interactions between all work 
system elements. 	  
As mentioned previously, the hospital met MU stage 2.  The hospital not only met the 10 
percent compliance requirement during the attestation period, but also continued to meet the 
requirements post attestation.  If the MU compliance percentage requirements increase over time, 
as suspected, the KBMA Optimization will need to reevaluate the current KBMA- overrides 
reasons, practices, and policies that were deemed acceptable at the beginning of the project.  
Currently, MU requires that 10 percent of medication orders created by providers be tracked 
using the eMAR.  It is expected that the percentage requirements increase i.e. 50 percent, and if 
this happens, current Wildcat MU compliance measures would fall short.  Post attestation MU 
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compliance percentage averages were almost identical to those found during the attestation 
period.  Therefore, minimal improvement was made in decreasing workarounds.	  
To increase MU compliance percentages, workarounds must decrease.  If any medication 
order is not scanned, the order becomes ineligible, as it did not meet MU requirements, 
regardless of the patient’s length of stay.  For example, if a patient had a length of stay of four 
days and received a scheduled medication each day, that medication must be scanned each time 
it is administered.  If one instance occurs when the medication is not scanned, the medication 
order becomes ineligible even if not scanning is correctly attributed to a work system issue and 
not considered a workaround.   
The User Error domain (Category 3) has the highest overall total workarounds of the 21 
domains; has the highest for all four Phases, and the totals did not decrease over time.  It is 
unclear why this occurred.  One would surmise that over time individuals would become 
acclimated with the technology and User Error reasons would begin to decrease.  However the 
opposite occurred, User Error totals doubled from Phase 1 to Phase 4.  The introduction of a new 
process can commonly disrupt workflows until that new process becomes routine.  Experienced 
nurses can have more difficulty changing methodology to the BCMA processes when compared 
to new graduates, who know of no other medication administration process.  There can be a 
number of reasons why the total number of workarounds may have increased, such as: time 
pressure, increased census, under-staffing, increased patient acuity, number of medications per 
patient.  Regardless further investigation is required. 	  
The Patient’s Own Medication (Category 1) domain totals were significant enough to 
warrant attention.  Optimization committee members from pharmacy were initially undecided 
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about whether or not to affix barcodes after verification to medications patient’s brought in from 
home.  A survey of policy at eight local hospitals in the Seacoast and southern New Hampshire 
related to verifying how barcoding was conducted when patient’s brought in their own 
medications from home.  The results were presented to the KBMA committee and although 
seven of the eight surveyed hospitals were affixing barcodes to patients own medications the 
pharmacy committee members decided they would not affix barcodes to patient’s own 
medication/s.  The members stated it was too time consuming, especially if patient’s only stayed 
for 24 hours.  Many patients’ are on numerous medications and the process to create individual 
barcodes for each medication was considered too laborious.  This continues to be a system issue 
resulting in nurse workarounds.	  
Barcode Damaged/Unreadable/No Other Package Available domains in Categories 1 and 
2, had significantly high totals overall.  Although the totals decreased over time, this domain 
remains remarkable in relation to the following discussion.  Anecdotally, several unit Directors 
mentioned two major reasons why nurses selected this override reason during their medication 
administrations.  First, the nurses indicated that they would scan a medication no more than 
twice.  If the medication would not scan, they would select the Barcode 
Damaged/Unreadable/No Other Package Available override reason.  The nurses reported they do 
not have time to straighten out barcodes or place packaging on a flat surface in attempt to flatten 
out or straighten the barcode.  Second, nurses reported that when they were too busy they would 
select this reason because it is conveniently one of the first choices in the drop menu.   
Both reasons provided have important implications and can be viewed as latent failures 
of the KBMA system design.  However the response from the optimization committee was, 
“well, we won’t be able to fix that” and “they’re being honest but there is nothing we can do 
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about that, so let’s move on to next agenda item”.  This was a lost opportunity for process 
improvement. 	  
At least nine of the 21-workaround domains identified during this evaluation were 
directly related to constraints found within certain eMAR screens that force nurses to free-text 
override reasons.  Ideally, these eMAR limitations would have been identified during the pilot 
implementation period and corrected.  However, some eMAR screens cannot be modified to 
conform to KBMA desired results.  Unfortunately, BCMA system constraints are not unique and 
a major contributor to workarounds. 	  
By Phase 4 several domain issues improved with the system optimization.  For instance, 
the LNA/RN not trained on KBMA domain was resolved by training all of the LNAs during 
phases 2 and 3.  During Phase 4 all new RN and LNA employees received KBMA training in 
their hospital orientation.  Technical issues were resolved as they were identified over time, 
decreasing overall totals in computer, scanner, and patient identification bracelet related 
problems. 	  
Some workarounds were clearly intentional tradeoffs, such as overriding the system for 
STAT medications, patient behavioral issues, and administering medications for a dying patient.  
Considering these situations, achieving 100 percent barcode scanning compliance is unlikely.  
However, by optimizing KBMA work system process issues workarounds should continue to 
decrease.	  
The structured observations corroborate the type of workarounds that were being reported 
in the weekly override scan reports.  One concern that emerged during observation was the 
process of nurses scanning the patient’s identification bracelet.  Many nurses did not identify 
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their patient according to hospital policy.  A serious potential negative consequence of the use of 
technology is when the nurse becomes reliant on the system itself.  Computer entry errors lead to 
system errors, and nurses must understand they are the last line of defense in the medication 
administration process.  	  
Observations occurred on a variety of shifts, times, and units.  Several units were alerted 
that there would be a visiting evaluator observing KBMA system medication administrations, 
and some units were not notified.  There were RN’s who were more relaxed during observation 
than others.  Several RN’s were very welcoming; a few seemed annoyed; while others took time 
explaining exactly what they were doing step by step.  It must be stated that it is possible not all 
workarounds were identified during the structured observations, due to the Hawthorne effect.  
This can occur when an individual improves an aspect of their behavior in response to their 
awareness of being observed.	  
BCMA systems have been developed with the intention of improving patient safety by 
facilitating adherence to all aspects of patient medication rights.  It is apparent from both the 
results of this program evaluation and existing literature that BCMA systems continue to be used 
incorrectly, consequently failing to provide intended patient safety benefits.  It should be 
unacceptable for organizations to implement BCMA systems with accepted workarounds in 
place, or at best only having a minimum reserved for particular circumstances.  Each defensive 
layer built into BCMA systems is intended to reduce variation at the point of care, and thus 





Accurate medication administration is required to improve quality and ensure patient 
safety.  However, results from this review confirm that nurses continue to develop new 
workarounds while using BCMA systems.  BCMA systems have the potential to prevent 
medication errors, although workarounds can eliminate the intended benefits.  Efforts to correct 
workarounds should focus on identifying work system process issues that are barriers for nurses 
using BCMA systems as designed.  Often, BCMA workarounds are system-level problems that 
in turn lead to unavoidable nurse workarounds.  Ideally, nurses, the significant user of BCMA 
systems, should be more directly involved, beginning to end, with new BCMA implementation.  
Nurse input in system selection and design may be beneficial and potentially reduce the need for 
most workarounds.	  
Leaders, such as the DNP in an organization can continue to identify workarounds 
resulting from work system process issues.  The DNP with advanced education and leadership 
skills are able to evaluate organizational practice policies and procedures for quality 
improvement using systems thinking.  The DNP can provide leadership in the evaluation and 
resolution of systems and process issues as they analyze and communicate critical elements 
necessary to resolve and sustain change. 	  
The SEIPS model of work system and patient safety provides healthcare leaders a model 
that has the ability to highlight the social and technical system elements and their interactions 
that can influence processes and patient safety outcomes.  The framework recognizes that change 




One limitation of this program evaluation was the inability to obtain the KBMA 
Optimization Committee minutes and agendas from January through May and again from 
September through December.  As a result it was difficult to accurately track all problems, 
particularly those initially identified at the beginning of the KBMA implementation process, and 
later, issues were being addressed in Phase 2 and 3.  Follow up conversations did take place with 
several KBMA committee members to help answer questions; however there would be more 
confidence in the results had the minutes been available. 	  
A second limitation occurred when the evaluator was hand coding the 10, 974 free text 
reasons.  When a free text reason potentially fit more then one category, a judgment was made 
for the category reason assignment.  This could have resulted in bias, potentially; another 
evaluator to provide inter-rater reliability would have been preferred. 
Finally, it is possible that the 21 free text override domains could have been further 
combined.  However, recommendations were made to the KBMA Optimization Committee for 
reexamining these domains.	  
Recommendations 
It is important for organizational leaders and key stakeholders to acknowledge BCMA 
workarounds and understand the processes that result in such workarounds.  Efforts to address 
KBMA workarounds should systematically investigate processes through the lens of the SEIPS 
framework.  Once identified leaders can then address each type, determine the causes, and 
working with the interdisciplinary team, identify and implement solutions to avoid incidence of 
such workarounds.  
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The nurse manager for nursing systems and support should continue to monitor and 
report KBMA Override Reason tracking reports on a quarterly basis to the KBMA Optimization 
Committee.  With the potential for MU compliance percentages to increase within the next few 
years, such review of reports allows key stakeholders the opportunity to provide ongoing updates 
and reminders of KBMA policies.	  
If the Barcode Damaged/Unreadable domain remains a primary problem, investigating a 
change to a 2-D barcode for the medication packages is worthy.  Currently, the hospital uses 
linear barcodes.  2-D barcodes offer an alternative solution to the linear barcode design which 
pharmacy currently uses.  It has been identified that nurses will often not take the time to 
straighten linear barcodes, thus 2-D barcodes have potential to reduce these workarounds. 
Implications for Practice 
A number of important implications for nursing practice arise from the findings of this 
program evaluation.  This evaluation has yielded information that supports the growing body of 
evidence related to nurse workarounds when using BCMA systems.  It is important for 
organizational leaders and key stakeholders to recognize the barriers nurses encounter while 
using BCMA systems in an effort to promote safer and more efficient patient care.  Nurses 
should be encouraged to report BCMA workarounds to better enable patient safety and the 
ongoing pursuit of practical solutions to emerging issues.  Technology in itself is not sufficient to 
prevent medication administration errors.  Technological patient safety protocols, processes, and 
procedures must be regularly revisited and revised to ensure that BCMA systems are being used 
correctly.  Understanding the design and implementation of a work system can improve patient 
safety, as it requires assessments of specific aspects of the work system in conjunction of work 
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system interactions.  These system interactions should be recognized as core attributes when 
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  &	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  is	  in	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  and	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  agreed	  that	  this	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  will	  be	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  from	  further	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Post	  KBMA	  	  
Implementation	  
Outline	  how	  your	  
organization	  is	  
currently	  using	  
the	  eMAR	  for	  
medication	  
documentation.	  
The	  following	  care	  units	  at	  CMC	  use	  the	  eMAR:	  
RMU,	  Mom’s	  Place,	  Special	  Care	  Nursery,	  E100,	  
E200,	  D100,	  D200,	  C100,	  ICU,	  PACU.	  	  This	  includes	  
all	  medication	  administration	  documentation	  
including	  medications	  given	  as	  an	  override.	  	  It	  is	  









Nurses	  and	  respiratory	  care	  practitioners	  utilize	  a	  
combination	  of	  rolling	  carts	  and	  devices	  that	  are	  
hardwired	  in	  the	  patient	  rooms.	  	  Due	  to	  the	  
freezing,	  latency,	  and	  loss	  of	  connection	  
problems,	  staff	  members	  have	  begun	  to	  develop	  
the	  habit	  of	  documenting	  medication	  
administration	  at	  the	  Nurses’	  Station	  rather	  than	  
at	  the	  patient’s	  bedside.	  	  This	  is	  a	  serious	  safety	  
concern.	  	  The	  nurses	  and	  respiratory	  care	  
practitioners	  cannot	  perform	  the	  required	  2-­‐	  
identifier	  checks	  without	  logging	  on	  to	  a	  device	  at	  
the	  patient’s	  bedside.	  	  For	  the	  fixed	  devices	  in	  the	  
patient’s	  rooms,	  the	  two	  major	  problems	  are:	  
devices	  being	  unplugged	  due	  to	  the	  lack	  of	  
adequate	  outlets	  in	  the	  rooms	  (in	  many	  cases,	  
the	  patient	  or	  visitor	  unplugs	  the	  CMC	  computer	  
to	  plug	  in	  their	  own	  personal	  computer),	  and	  
either	  the	  patient’s	  body	  or	  another	  piece	  of	  
equipment	  is	  obstructing	  access	  to	  the	  fixed	  
device.	  	  A	  frequent	  complaint	  with	  the	  rolling	  
carts	  has	  been	  the	  slowness	  of	  their	  
performance.	  	  Staff	  members	  report	  that	  the	  
rolling	  carts	  are	  significantly	  slower	  and	  less	  
reliable	  than	  the	  fixed	  devices	  at	  the	  Nurse’s	  
Station.	  	  Special	  Care	  Nursery	  (SCN)	  has	  one	  
rolling	  cart	  in	  their	  stabilization	  room.	  	  There	  are	  
no	  rolling	  carts	  in	  the	  nursery.	  
New	  computers	  and	  
computer	  on	  wheels	  







Is	  your	  current	  
device	  selection	  
meeting	  your	  





We	  need	  to	  explore	  rolling	  carts	  that	  take	  up	  less	  space,	  
have	  faster	  performance,	  do	  not	  experience	  a	  loss	  of	  
connection,	  and	  do	  not	  freeze.	  	  It	  may	  also	  be	  time	  to	  
reevaluate	  other	  portable	  devices	  that	  could	  meet	  the	  
need	  of	  bedside	  access	  for	  medication	  administration	  2-­‐
identifier	  checks	  and	  all	  other	  aspects	  of	  safe	  bedside	  
medication	  administration.	  
New	  computer	  
on	  wheels	  were	  
purchased.	  
Describe	  the	  






Nurses,	  nursing	  assistants,	  respiratory	  care	  providers,	  
dietitians,	  speech	  language	  pathologists,	  occupational	  
therapists,	  physical	  therapists,	  pastoral	  care,	  IV	  therapists,	  
social	  workers,	  and	  RN	  case	  managers	  record	  99%	  of	  all	  
clinical	  documentation	  in	  our	  EMR	  (Sunrise).	  	  Radiology	  
nurses,	  preadmission	  testing	  (PAT)	  nurses,	  and	  admission	  
nurses	  complete	  the	  patient	  profile	  and	  historical	  
medications.	  
No	  change.	  
Is	  the	  eMAR	  
currently	  used	  





If	  so,	  please	  
describe	  the	  
workflow	  and	  
your	  plans	  for	  
use	  of	  KBMA	  in	  
these	  areas.	  
The	  Pharmacy	  is	  not	  open	  from	  11:00	  pm	  until	  7:00	  am.	  	  
For	  this	  reason,	  medications	  cannot	  be	  verified	  during	  this	  
period	  of	  time.	  	  As	  a	  safety	  mechanism,	  nurses	  confirm	  
appropriate	  medication,	  dose	  and	  indication	  with	  a	  
second	  nurse	  when	  override	  meds	  need	  to	  be	  
administered.	  	  The	  name	  of	  the	  verifying	  nurse	  I	  entered	  
on	  the	  medication	  administration	  form	  and	  displays	  on	  
the	  verifying	  nurse’s	  Signature	  Manager.	  	  Within	  the	  limits	  
of	  out	  override	  policy,	  medications	  can	  be	  administered	  




Is	  the	  eMAR	  
currently	  used	  
in	  any	  location	  





When	  the	  patient	  is	  in	  an	  outpatient	  status,	  and	  is	  later	  
converted	  to	  an	  inpatient	  or	  OIB	  status,	  it	  is	  possible	  for	  
their	  account	  number	  to	  change.	  	  For	  this	  reason,	  we	  
currently	  do	  not	  allow	  orders	  to	  be	  entered	  on	  any	  patient	  
prior	  to	  the	  patient	  actually	  being	  placed	  in	  a	  bed	  on	  a	  





Flushes	  are	  not	  documented	  on	  the	  eMAR.	  	  Nurses	  do	  








If	  yes,	  describe	  
the	  process.	  
Lidoderm	  patches	  are	  built	  as	  an	  order	  set	  with	  tasks	  for	  
both	  the	  application	  and	  removal	  of	  the	  patch.	  	  We	  need	  
to	  ensure	  that	  this	  type	  of	  order	  set	  has	  been	  built	  for	  
each	  medication	  that	  has	  the	  transdermal	  patch	  route.	  
Order	  sets	  were	  








brought	  to	  the	  
bedside	  in	  unit	  
dose	  
packaging?	  





No,	  Insulin	  doses	  are	  drawn	  up	  and	  double-­‐checked	  while	  
the	  nurses	  are	  still	  in	  the	  medication	  room.	  	  (See	  insulin	  
preparation	  and	  administration	  description	  below).	  	  
Insulin	  requires	  a	  co-­‐signature.	  
Some	  oral	  liquids	  such	  as	  Vancomycin	  come	  in	  a	  bottle	  
from	  which	  the	  nurse	  pours	  the	  prescribed	  dose.	  	  Silver	  
nitrate	  sticks	  come	  in	  a	  container	  with	  several	  sticks	  that	  












Half	  and	  even	  quarter	  tabs	  may	  need	  to	  be	  administered.	  	  
There	  is	  no	  information	  in	  the	  body	  of	  the	  order	  or	  in	  the	  
Instructions	  section	  guiding	  the	  nurse	  to	  administer	  a	  half	  
or	  quarter	  tablet.	  	  The	  nurse	  is	  expected	  to	  calculate	  when	  
a	  half	  or	  quarter	  tablet	  is	  needed	  as	  the	  dose	  to	  be	  
administered.	  
The	  organization	  has	  adopted	  a	  new	  policy	  that	  when	  a	  
newly	  ordered	  medication	  requires	  more	  than	  three	  pills	  
to	  give	  the	  prescribed	  dose,	  the	  nurse	  is	  required	  to	  check	  
the	  calculation	  with	  the	  peer	  and	  note	  whether	  the	  
pharmacist	  has	  included	  a	  message	  in	  the	  dispensing	  
instructions	  section	  of	  the	  task	  description	  that	  confirms	  
the	  number	  of	  pills/tablets	  required.	  
	  
Are	  there	  any	  
medications	  
that	  require	  a	  
co-­‐signature?	  




Our	  policy	  is	  to	  have	  high-­‐risk	  medications	  require	  a	  co-­‐
signature.	  	  This	  co-­‐signature	  creates	  a	  flag	  and	  displays	  on	  
the	  nurse’s	  signature	  manager.	  	  Our	  high-­‐risk	  medications	  
include:	  Heparin,	  Insulin<	  Chemotherapy,	  and	  medications	  
administered	  via	  the	  epidural,	  intrathecal,	  and	  PCA	  routes	  
of	  administration.	  	  Epidural	  and	  PCA	  solutions	  and	  pump	  
settings	  must	  be	  double-­‐checked	  by	  the	  nurses,	  and	  a	  co-­‐















• How	  is	  it	  
dispensed?	  
	  
• Where	  is	  it	  
prepared?	  
The	  various	  types	  of	  insulin	  are	  available	  in	  vials	  in	  the	  
medication	  refrigerator	  in	  the	  medication	  rooms	  on	  the	  
inpatient	  care	  units.	  	  The	  nurse	  logs	  onto	  the	  medication	  
room	  computer,	  pulls	  up	  the	  patient’s	  eMAR,	  reads	  the	  
type	  of	  insulin	  to	  be	  administered,	  calculates	  the	  amount	  
of	  physiologic	  insulin	  to	  be	  administered,	  goes	  to	  the	  
refrigerator,	  obtains	  the	  correct	  vial	  that	  is	  not	  patient	  
specific,	  and	  withdrawals	  the	  correct	  number	  of	  ordered	  
units.	  	  At	  this	  point,	  the	  insulin	  calculations,	  correct	  type	  
of	  insulin,	  and	  the	  number	  of	  units	  they	  observe	  to	  be	  in	  
the	  syringe	  are	  all	  verified	  by	  a	  second	  nurse.	  	  No	  
information	  is	  given	  to	  the	  second	  nurse.	  	  In	  many	  cases,	  
for	  the	  sake	  of	  convenience,	  the	  verifying	  nurse	  is	  given	  
the	  patient’s	  CBG	  result	  and	  the	  number	  of	  carbohydrates	  
ingested.	  	  Some	  verifying	  nurses	  will	  check	  the	  most	  
recent	  CBG	  result	  themselves.	  	  The	  verifying	  nurse	  is	  
required	  to	  calculate	  the	  dose	  from	  the	  information	  on	  
the	  eMAR,	  and	  then	  handed	  the	  vial	  and	  syringe	  for	  their	  
confirmation	  that	  the	  correct	  type	  of	  insulin	  is	  being	  given	  
and	  the	  correct	  dose	  has	  been	  calculated	  in	  the	  syringe.	  	  
The	  vial	  of	  insulin	  is	  then	  returned	  to	  the	  refrigerator.	  	  
There	  is	  some	  variation,	  as	  some	  nurse	  will	  start	  their	  



















Due	  to	  recent	  system	  performance	  issues,	  both	  the	  nurse	  
and	  respiratory	  care	  practitioners	  are	  less	  consistent	  in	  
documenting	  medication	  administration	  at	  the	  patient’s	  
bedside.	  	  The	  reason	  staff	  members	  cite	  for	  not	  
documenting	  medication	  administration	  at	  the	  bedside	  
include:	  fixed	  device	  not	  plugged	  in,	  fixed	  device	  not	  
working,	  lack	  of	  availability	  of	  a	  rolling	  cart,	  rolling	  carts	  
are	  slow,	  the	  rolling	  cart	  losses	  internet	  connection,	  and	  
the	  image	  freezes	  on	  the	  screen	  of	  the	  rolling	  carts.	  	  In	  
these	  instances	  staff	  members	  state	  that	  they	  do	  not	  have	  
time	  to	  go	  find	  another	  cart,	  plug	  it	  in,	  or	  explore	  what	  is	  
wrong	  with	  the	  cart/fixed	  device,	  and	  then	  login	  and/or	  









Describe	  the	  process	  
when	  a	  medication	  
is	  administered	  from	  
a	  bulk	  container:	  
	  
• Ointment/cream
s	  from	  tubes	  or	  
jars	  
• Eye	  drops	  from	  
bottles	  





There	  are	  limited	  numbers	  of	  medications	  that	  are	  
administered	  from	  a	  bulk	  container.	  	  These	  
medications	  include	  spirits	  of	  peppermint	  and	  
hurricane	  spray.	  	  The	  pharmacy	  compounds	  several	  
products	  including:	  Butt	  Balm,	  Vancomycin	  and	  













For	  all	  clinical	  areas?	  
Yes	  we	  use	  and	  have	  a	  policy	  for	  standard	  
administration	  times.	  	  There	  are	  exceptions	  to	  standard	  
medication	  administration	  times.	  	  For	  example,	  the	  
first	  dose	  of	  an	  antibiotic	  will	  be	  given	  within	  two	  hours	  
of	  the	  time	  of	  the	  order.	  	  Subsequent	  doses	  will	  
automatically	  be	  scheduled	  based	  on	  the	  time	  the	  first	  
dose	  is	  marked	  as	  done	  and	  the	  frequency.	  	  SCIP	  
postoperative	  antibiotics	  and	  postpartum	  antibiotics	  
will	  be	  administered	  based	  on	  the	  administration	  time	  
of	  the	  last	  dose	  in	  the	  OR.	  	  Enoxaparin	  (Lovenox)	  and	  
Fondapariux	  (Atrixtra)	  will	  be	  scheduled	  based	  of	  the	  
administration	  time	  of	  the	  first	  dose.	  	  We	  employ	  the	  
50%	  rule.	  	  The	  50%	  rule	  refers	  to	  half	  of	  the	  length	  of	  
time	  between	  doses.	  	  When	  less	  than	  50%	  of	  the	  
scheduled	  interval	  has	  passed,	  the	  medication	  may	  be	  
administered	  to	  the	  patient	  and	  the	  next	  dose	  will	  be	  
administered	  according	  to	  the	  standard	  medication	  
administration	  times.	  	  When	  greater	  than	  50%	  of	  the	  
interval	  has	  passed,	  the	  medication	  should	  not	  be	  
administered	  until	  the	  next	  scheduled	  standard	  
medication	  administration	  time.	  	  Exception	  to	  the	  50%	  
rule	  for	  IV	  antibiotics:	  when	  less	  than	  50%	  of	  the	  
scheduled	  interval	  has	  passed,	  the	  IV	  antibiotics	  may	  
be	  administered	  to	  the	  patient	  in	  the	  next	  dose	  will	  be	  
administered	  to	  the	  standard	  medication	  
administration	  times.	  	  When	  greater	  than	  the	  50%	  of	  
the	  medication	  interval	  has	  passed,	  the	  IV	  antibiotics	  
may	  be	  administered	  to	  the	  patient,	  then	  reschedule	  
subsequent	  doses.	  	  	  
No	  change.	  
 65 
Is	  there	  a	  defined	  




If	  so,	  please	  
describe.	  
	  
As	  described	  above	  with	  the	  50%	  rule.	  
No	  change.	  




Providers	  do	  not	  have	  access	  to	  the	  eMAR.	  	  If	  a	  
provider	  administers	  a	  medication,	  the	  nurse	  marks	  the	  
medication	  as	  done	  by	  other,	  inserts	  the	  providers	  
name	  in	  the	  order	  form,	  which	  automatically	  goes	  to	  
the	  provider’s	  signature	  manager	  for	  signing.	  
No	  change.	  
Are	  there	  any	  other	  
projects	  ongoing	  
that	  may	  interfere	  




While	  there	  are	  numerous	  other	  projects	  that	  will	  be	  
competing	  with	  the	  KBMA	  implementation,	  staff	  
understands	  the	  seriousness	  of	  this	  project	  and	  will	  be	  
required	  to	  attend	  2	  to	  3	  hours	  of	  required	  education.	  	  
Education	  must	  be	  completed	  in	  order	  to	  administer	  
medications	  in	  KBMA.	  
NA	  
Staffing	  and	  Hours	  
Is	  the	  pharmacy	  
open	  24	  hours?	  
	  
If	  no,	  what	  are	  the	  
pharmacy	  hours?	  
Not	  currently	  but	  should	  be	  by	  the	  time	  KBMA	  is	  
implemented.	  
	  







Are	  the	  pharmacists	  
on	  the	  nursing	  units?	  
	  
	  
If	  yes,	  do	  
pharmacists	  
enter/verify	  orders	  
from	  the	  floors?	  
Only	  two	  Pharmacists	  cover	  the	  hospital	  Monday	  thru	  











Do	  you	  outsource	  




Please	  describe	  in	  
detail	  functions	  that	  
are	  outsourced.	  





High	  volume	  IVPB	  and	  Drips	  (Vancomycin,	  Cefazolin	  
2gm,	  Phenylephrine	  100mg/250NS,	  Norepinephrine	  
and	  Dexmedtomidine.	  











clinicians	  to	  use	  
outsourced	  barcode	  
labels	  or	  pharmacy	  
generated	  bar	  code	  
labels?	  
use	  the	  Barcode	  on	  the	  item,	  as	  they	  are	  floor	  stock	  
items.	  	  Others	  such	  as	  some	  of	  the	  IVPB	  will	  be	  
dispensed	  from	  the	  pharmacy	  with	  a	  specific	  label	  with	  
a	  barcode.	  







Yes	   No	  Change	  





Yes	   No	  Change	  
Pharmacy	  Implementation	  Team	  



















formulary,	  new	  item	  
configuration?	  
	  





















Are	  there	  any	  
other	  projects	  
ongoing	  that	  












system	  a	  profile	  
system?	  
Yes	   No	  change.	  
	  






order	  first?	  	  
	  














Are	  there	  floor	  
stock	  
medications	  on	  
the	  floor	  that	  




































Are	  the	  items	  
stocked	  in	  the	  
automated	  
dispensing	  
machine	  and	  on	  
the	  floor	  as	  
floor	  stock	  
recognized	  as	  































In	  the	  case	  of	  
items	  such	  as	  
TPN,	  does	  the	  

















How	  are	  the	  
labels	  for	  these	  
items	  
generated	  and	  
do	  they	  contain	  
a	  bar	  code?	  
The	  labels	  are	  produced	  through	  the	  compounding	  
system	  (Abacus	  Software),	  which	  contains	  a	  bar	  code.	  	  
























Manual	  for	  all	  liquid	  products	  and	  syringes.	  	  Automated	  























this	  volume	  is	  
repackaged	  for	  
pediatrics?	  




this	  volume	  are	  
adult	  
medications?	  














If	  yes,	  can	  it	  
generate	  these	  
bar	  codes	  for	  all	  
package	  types?	  
No.	  	  Barbara	  Case	  is	  in	  the	  process	  of	  looking	  at	  newer	  
repackagers	  and	  software	  that	  will	  have	  the	  abilities	  to	  


















is	  bar	  coded	  by	  
the	  
manufacturer?	  





use	  a	  company	  
or	  wholesaler	  
to	  repackage	  
and/or	  bar	  code	  
medications?	  
	  
If	  yes,	  would	  
this	  be	  an	  
option	  for	  your	  
organization?	  
CMC	  is	  currently	  using	  a	  company	  that	  repackages	  out	  
high	  volume	  oral	  medications	  that	  are	  bought	  in	  bulk.	  	  











for	  bar	  codes	  to	  
be	  printed	  on	  
the	  IV	  Fluid/IV	  
Piggyback	  
labels?	  
Yes	   No	  change.	  
	  
Do	  your	  current	  
medication	  
labels	  contain	  a	  
bar	  code?	  	  
If	  not,	  is	  there	  
room	  on	  the	  
label	  for	  a	  bar	  
code?	  
Yes	   No	  change.	  
	  




are	  in	  the	  
pharmacy	  
system?	  
1800	   Unable	  to	  obtain.	  





on	  the	  eMAR?	  










system	  after	  a	  
new	  item	  is	  
purchased?	  
The	  new	  item	  that	  is	  brought	  in	  by	  the	  buyer	  gives	  the	  







If	  an	  item	  on	  




Yes	   No	  change.	  
	  
Are	  you	  up	  to	  
date	  on	  your	  
Multum	  
updates?	  
If	  not,	  when	  
was	  the	  last	  
update	  run?	  
Yes	   No	  change.	  
	  







Is	  there	  a	  delay	  
(please	  
specify)?	  
All	  medications	  are	  discontinued	  after	  1	  hour	  in	  Sunrise	  
by	  the	  system.	  
No	  change.	  
	  
If	  the	  patient’s	  
discharge	  is	  
canceled,	  is	  the	  
pharmacy	  
required	  to	  
reenter	  all	  the	  
medication	  
orders?	  













If	  yes,	  what	  
types	  of	  orders	  










Some	  providers	  are	  currently	  on	  paper,	  TPN,	  Chemo,	  




When	  a	  patient	  
is	  transferred,	  
do	  all	  orders	  
get	  	  
discontinued	  
and	  then	  new	  
orders	  are	  
entered	  or	  do	  
the	  existing	  
orders	  remain	  
on	  profile	  and	  




Existing	  orders	  remain	  on	  the	  profile	  and	  only	  new	  
orders	  entered	  and	  non-­‐reordered	  meds	  discontinued.	  
No	  change.	  
	  




By	  Nursing.	   No	  change.	  
	  
Are	  there	  any	  
other	  projects	  
ongoing	  that	  











Can	  test	  patients	  




We	  have	  a	  TEST	  environment.	  	  There	  are	  TEST	  patients	  
in	  PROD	  but	  they	  have	  no	  eMAR.	  
NA	  
Is	  the	  test	  
environment	  





If	  no,	  when	  was	  
the	  last	  
synchronization?	  
SCM	  -­‐	  Yes	  






New	  TEST	  will	  be	  made	  prior	  to	  KBMA	  testing	  in	  6.1	  
	  
NA	  
	  
	  
 
	  
